ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.
about
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@en
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@nl
type
label
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@en
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@nl
prefLabel
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@en
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@nl
P2093
P2860
P356
P1433
P1476
ERpS294 is a biomarker of liga ...... er target for CDK2 inhibition.
@en
P2093
Ben Ho Park
Byron Hann
Christopher C Benz
Daniel E Rothschild
Gary K Scott
Julia Malato
Katya Frazier
Ravneet Kaur
Serenella Eppenberger-Castori
P2860
P304
83432-83445
P356
10.18632/ONCOTARGET.12735
P407
P577
2016-10-18T00:00:00Z